Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy AVROBIO stock
Learn how to easily invest in AVROBIO stock.
AVROBIO is a biotechnology business based in the US. AVROBIO shares (AVRO) are listed on the NASDAQ and all prices are listed in US Dollars. AVROBIO employs 122 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy AVROBIO stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – AVRO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
AVROBIO stock price (NASDAQ: AVRO)Use our graph to track the performance of AVRO stocks over time.
AVROBIO shares at a glance
|Latest market close||$1.19|
|52-week range||$0.56 - $1.93|
|50-day moving average||$1.18|
|200-day moving average||$0.93|
|Wall St. target price||$3.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.56|
Buy AVROBIO stocks from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy AVROBIO stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
AVROBIO price performance over time
Historical closes compared with the close of $1.19 from 2023-03-17
|1 week (2023-03-13)||-1.65%|
|1 month (2023-02-17)||-29.59%|
|3 months (2022-12-20)||50.63%|
|6 months (2022-09-20)||53.93%|
|1 year (2022-03-16)||N/A|
|2 years (2021-03-19)||-90.50%|
|3 years (2020-03-20)||13.65|
|5 years (2018-03-16)||N/A|
|Gross profit TTM||$0|
|Return on assets TTM||-39.07%|
|Return on equity TTM||-74.8%|
|Market capitalisation||$54.3 million|
TTM: trailing 12 months
AVROBIO share dividends
We're not expecting AVROBIO to pay a dividend over the next 12 months.
AVROBIO share price volatility
Over the last 12 months, AVROBIO's shares have ranged in value from as little as $0.56 up to $1.93. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AVROBIO's is 1.6286. This would suggest that AVROBIO's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
AVROBIO, Inc. , a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. .
AVROBIO in the news
AVROBIO to Participate in Cowen’s 43rd Annual Health Care Conference
Frequently asked questionsWhat percentage of AVROBIO is owned by insiders or institutions?
Currently 2.678% of AVROBIO shares are held by insiders and 53.079% by institutions. How many people work for AVROBIO?
Latest data suggests 122 work at AVROBIO. When does the fiscal year end for AVROBIO?
AVROBIO's fiscal year ends in December. Where is AVROBIO based?
AVROBIO's address is: Building 300, Cambridge, MA, United States, 02139 What is AVROBIO's ISIN number?
AVROBIO's international securities identification number is: US05455M1009 What is AVROBIO's CUSIP number?
AVROBIO's Committee on Uniform Securities Identification Procedures number is: 05455M100
More guides on Finder
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Ask an Expert